Michael Perry, MD

Medical Director - Tampa Clinic

DrPerryMichael Perry, M.D., is the medical director of our Tampa facility. He received his medical degree from St. George’s University School of Medicine and completed his residency at Mount Sinai Hospital in Hartford, Connecticut.

Board-certified in internal medicine through the American Board of Internal Medicine, he is frequently sought out for his expertise and reputation for patient-centered care. Dr. Perry is a regular contributor to leading medical publications.

  • American Board of Internal Medicine, 1989
  • Educational Commission for Foreign Medical Graduates, 1985
  • Federation Licensing Examination Components I and II, 1989
  • Special Purpose Examination, 2004
  • 1976-1981 Undergraduate
    University of South Florida
    Tampa, FL
    B.A. in Biology
  • 1982-1985 Medical School
    St. George’s University School of Medicine
    Grenada, West Indies
  • 1986-1989 Residency and Internship in Internal Medicine
    Mount Sinai Hospital
    Hartford, CT
  • 1989-2004 Medical Director and Lab Director
    Internal Medicine, Sports Medicine
    Gainesville, FL
  • 2004 Medical Director
    Laserscopic Spine Center
    Internal Medicine, Sports Medicine
    Gainesville, FL
  • 2005-Present Co-Founder and Chief Medical Director
    Laser Spine Institute
    Corporate Headquarters – Tampa, FL
    Ambulatory Surgical Center – Tampa, FL; Scottsdale, AZ; Wayne, PA; Oklahoma City, OK
    Gainesville, FL
  • 2014-Present Owner
    Lung Institute
    Regenerative Medicine
    Pittsburgh, PA; Scottsdale, AZ; Nashville, TN
  • Who’s Who Among American Universities and Colleges, 1981
  • Abdool Islami Award for Outstanding Academic Performance, 1985
  • Modern Healthcare Trustee of the Year, For-Profit Healthcare Company, 2012
  • American College of Physicians
  • American Medical Association
  • Fellow International College of Surgeons
  • American College of Sports Medicine
  • American College of Physician Executives
  • Adjunct Clinical Assistant Professor LECOM College of Osteopathic Medicine Florida

If you or a loved one is living with a lung disease and would like to learn more about all available treatment options, we can help. Please contact a patient coordinator today at (800) 729-3065 to schedule a free consultation.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.